Latest Interviews

The Global Biomedical Industry: Preserving U.S. Leadership

Ross Duvall, Jeff

The Milken Institute's latest report highlights the critical role of the U.S. biomedical sector, which supports over 5 million jobs but faces declining competitiveness due to outdated tax structures and shrinking domestic STEM enrollment. With the era of blockbuster drugs ending and rivals like China rapidly advancing in nanotechnology, the study argues that immediate policy reforms are essential to restore American leadership. Key recommendations include permanently enhancing the R&D tax credit by 25%, reducing the federal corporate tax rate to the advanced economy average of 23%, and increasing funding for the FDA and NIH to better accommodate personalized medicine frameworks.